UTI Healthcare Fund - Growth - Direct Plan

  • Previous Nav

  • Net Change on 21-10-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
UTI Healthcare Fund - Direct Plan - Growth Option -2.38 -1.27 29.59 25.70 13.04 16.29
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care -3.06 -2.26 29.00 20.47 9.28 15.31
S&P BSE Health Care - TRI -3.06 -2.05 29.74 21.28 9.99 15.42

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
UTI Healthcare Fund - Direct Plan - Growth Option Jan 01, 2013 29.59 25.70 13.04 1.24 879.57
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 34.35 26.44 16.65 0.90 5,474.07
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 28.10 24.25 10.74 1.07 2,001.26
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 30.64 27.14 14.63 1.06 590.03

Fund Holdings as on 30-September-2021

  • EQ DR REDDY'S LABORATORIES LTD.

  • EQ SUN PHARMACEUTICALS INDUSTRIES LTD.

  • EQ CIPLA LTD.

  • EQ AUROBINDO PHARMA LTD.

  • EQ DIVIS LABORATORIES LTD.

  • EQ FORTIS HEALTHCARE LTD.

  • EQ AJANTA PHARMA LIMITED

  • EQ ERIS LIFESCIENCES LTD

  • EQ IPCA LABORATORIES LTD.

  • EQ APOLLO HOSPITALS ENTERPRISE LTD.

  • EQ J.B.CHEMICALS & PHARMACEUTICALS LTD

  • EQ FDC LIMITED

  • EQ ALKEM LABORATORIES LTD

  • EQ CADILA HEALTHCARE LTD.

  • EQ KRISHNA INSTITUTE OF MEDICAL SCIENCE LTD

  • EQ AMI ORGANICS LTD

  • EQ NARAYANA HRUDAYALAYA LTD

  • EQ LUPIN LTD.

  • EQ ABBOTT INDIA LTD.

  • EQ ADVANCED ENZYME TECHNOLOGIES LTD

  • NET CURRENT ASSETS

  • EQ ALEMBIC PHARMACEUTICALS LTD.

  • EQ METROPOLIS HEALTHCARE LTD

  • EQ GLAND PHARMA LTD

  • EQ POLY MEDICURE LTD.

  • EQ TORRENT PHARMACEUTICALS LTD.

  • EQ SUVEN PHARMACEUTICALS LTD

  • EQ PROCTOR & GAMBLE HEALTH LTD

  • EQ WINDLAS BIOTEC LTD

  • EQ LAURUS LABS LTD.

  • CLEARING CORPORATION OF INDIA LTD. STD - 92 DaysMargin deposit

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Deposits

  • Equity

View More

About UTI Healthcare Fund

Scheme Analysis

UTI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to UTI Mutual Fund. It was launched on 01-Jan-2013 and currently has an AUM of ₹879.57 crore. UTI Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of UTI Healthcare Fund ended down ₹-0.64(-0.36%)yesterday to ₹180.1354.

Among its top 3 holdings the fund has exposure to EQ DR REDDY'S LABORATORIES LTD., and

The UTI Healthcare Fund is managed by V. Srivatsa .

Fund House Contact

UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 66786666
service@uti.co.in
+91 (22) 66786503,56786578
www.utimf.com